| Sexed work: Gender, race, and resistance in a Brooklyn drug market L Maher Oxford University Press, 1997 | 1056 | 1997 |
| Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees K Dolan, AL Wirtz, B Moazen, M Ndeffo-Mbah, A Galvani, SA Kinner, ... The Lancet 388 (10049), 1089-1102, 2016 | 749 | 2016 |
| The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ... Hepatology 59 (1), 109-120, 2014 | 515 | 2014 |
| Policing and public health: Law enforcement and harm minimization in a street-level drug market L Maher, D Dixon British journal of criminology 39 (4), 488-512, 1999 | 464 | 1999 |
| Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs L Platt, S Minozzi, J Reed, P Vickerman, H Hagan, C French, A Jordan, ... Cochrane Database of Systematic Reviews, 2017 | 373 | 2017 |
| Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis L Platt, S Minozzi, J Reed, P Vickerman, H Hagan, C French, A Jordan, ... Addiction 113 (3), 545-563, 2018 | 359 | 2018 |
| Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic A Dunlop, B Lokuge, D Masters, M Sequeira, P Saul, G Dunlop, J Ryan, ... Harm reduction journal 17 (1), 26, 2020 | 316 | 2020 |
| Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection RA Bull, F Luciani, K McElroy, S Gaudieri, ST Pham, A Chopra, ... PLoS pathogens 7 (9), e1002243, 2011 | 299 | 2011 |
| Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia L Maher, B Jalaludin, KG Chant, R Jayasuriya, T Sladden, JM Kaldor, ... Addiction 101 (10), 1499-1508, 2006 | 292 | 2006 |
| Women in the street-level drug economy: Continuity or change? L Maher, K Daly Feminist theories of crime, 69-95, 2017 | 279 | 2017 |
| Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine J Grebely, M Prins, M Hellard, AL Cox, WO Osburn, G Lauer, K Page, ... The Lancet infectious diseases 12 (5), 408-414, 2012 | 275 | 2012 |
| Contrasting crime general and crime specific theory: The case of hot spots of crime D Weisburd, L Maher, L Sherman, M Buerger, E Cohn, A Petrosino New directions in criminological theory, 45-70, 2023 | 263 | 2023 |
| Women on the edge of crime: Crack cocaine and the changing contexts of street-level sex work in New York City L Maher, R Curtis Crime, law and social change 18, 221-258, 1992 | 226 | 1992 |
| Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review S Bajis, GJ Dore, B Hajarizadeh, EB Cunningham, L Maher, J Grebely International Journal of Drug Policy 47, 34-46, 2017 | 224 | 2017 |
| Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis J Stone, H Fraser, AG Lim, JG Walker, Z Ward, L MacGregor, A Trickey, ... The Lancet Infectious Diseases 18 (12), 1397-1409, 2018 | 222 | 2018 |
| Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention K Page, MD Morris, JA Hahn, L Maher, M Prins Clinical infectious diseases 57 (suppl_2), S32-S38, 2013 | 208 | 2013 |
| HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment J Iversen, K Page, A Madden, L Maher JAIDS Journal of Acquired Immune Deficiency Syndromes 69, S176-S181, 2015 | 200 | 2015 |
| Modelling the hepatitis C virus epidemic in Australia K Razali, HH Thein, J Bell, M Cooper-Stanbury, K Dolan, G Dore, ... Drug and alcohol dependence 91 (2-3), 228-235, 2007 | 173 | 2007 |
| Uptake of hepatitis C treatment among people who inject drugs attending N eedle and S yringe P rograms in A ustralia, 1999–2011 J Iversen, J Grebely, L Topp, H Wand, G Dore, L Maher Journal of viral hepatitis 21 (3), 198-207, 2014 | 162 | 2014 |
| High hepatitis C incidence in new injecting drug users: a policy failure? L Maher, J Li, B Jalaludin, KG Chant, JM Kaldor Australian and New Zealand journal of public health 31 (1), 30-35, 2007 | 158 | 2007 |
